Zhengye Biotechnology’s (NASDAQ:ZYBT – Get Free Report) quiet period is set to end on Monday, February 17th. Zhengye Biotechnology had issued 1,500,000 shares in its IPO on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During the company’s quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Zhengye Biotechnology Stock Performance
Zhengye Biotechnology stock opened at $4.99 on Friday. Zhengye Biotechnology has a 12 month low of $3.70 and a 12 month high of $6.10.
Zhengye Biotechnology Company Profile
Featured Stories
- Five stocks we like better than Zhengye Biotechnology
- Ride Out The Recession With These Dividend KingsĀ
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Short Selling – The Pros and Cons
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- 5 discounted opportunities for dividend growth investors
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.